We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Fully Automated Coagulation System Launched

By LabMedica International staff writers
Posted on 04 Jul 2017
Coagulation tests measure the blood’s ability to clot and clotting disorders may be a sign of liver disease, thrombophilia (excessive clotting), or hemophilia (inability to clot normally). More...
Coagulation tests are also performed to monitor patients who are taking medications that can affect clotting.

These clotting test aid physicians in assessing the patients’ risk of excessive bleeding or clotting and in determining the patient care pathway. Delays in coagulation testing are often related to sample errors and manual errors in the testing process. A coagulometer is the medical laboratory analyzer used for testing of the hemostasis system.

The CP3000 coagulation system features small sample volume requirements, and offers high throughput in a compact footprint. With a broad assay menu and rapid result turnaround time, the CP3000 coagulation system can meet the workflow needs of laboratories of all sizes, while providing high quality and reliable results. The system offers an expanded menu of barcoded reagents to reduce data entry errors. With a unique ability to visualize and automate Mixing Studies, the CP3000 coagulation system can help clinicians quickly interpret results.

The system also connects to the ACCELERATOR a3600 (Abbott, Abbott Park, IL, USA) automation track, which provides additional flexibility to meet the needs of the laboratory. The CP3000 coagulation system seamlessly integrates with Abbott’s suite of informatics solutions, which help accelerate efficiency in high test volume laboratories where resources may be limited and space and time is at a premium. Capabilities like Abbotts AlinIQ informatics and service offerings streamline operations and provide intelligent laboratory insights through common reporting and dashboard views make it easy for healthcare providers to read and interpret patient results.

Dr. Chandra Poonam, laboratory director of the Gulf Diagnostic Center Hospital said, “The CP3000 coagulation system has been a great addition to our lab. It does not occupy a lot of space, and its automated processes and user-friendly design have reduced the burden on our lab staff and pathologists. We have been pleased with how quickly the system produces accurate results that are used to guide treatment decisions for our patients.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Clinical Informatics Platform
CLARION™
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.